Notify me when Merck & Co., Inc. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EVAX | Evaxion Biotech A/S | American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share | 20% | $105,531,938 | 63,004,142 | Merck & Co., Inc. | 31 Jan 2025 | ||
| PSNL | Personalis, Inc. | Common Stock, $0.0001 par value per share | 16% | $53,792,132 | 14,044,943 | Merck & Co., Inc. | 19 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|